Bharat Biotech’s Covaxin and the Serum Institute of India’s Covishield were recommended by a government-appointed panel to the Drugs Controller General of India (DCGI) for emergency use in the last two days.
(Photo: PIB)
Prime Minister Narendra Modi, minutes after DCGI announced the approval for two coronavirus vaccines, said it would make every Indian proud that the two were “made in India”.
“It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion,” PM Modi said in a tweet.
Bharat Biotech’s Covaxin and the Serum Institute of India’s Covishield were recommended by a government-appointed panel to the Drugs Controller General of India (DCGI) for emergency use in the last two days.
Advertisement
India’s first indigenous vaccine developed by Hyderabad-based Biotech with backing from Indian Council of Medical Research (ICMR), was recommended to the DCGI on Saturday.
Ahead of the actual vaccination drive, the Ministry of Health & Family Welfare conducted a nationwide mock drill at 285 session sites to test the end-to-end planned operations and the mechanism that has been set up to ensure smooth conduct of the COVID19 vaccination that is expected to begin soon.
Union Health Minister Harsh Vardhan had said that free coronavirus vaccines will be given in the first phase to three crore people who have been on the frontline in the fight against the disease.
The government will give priority to 1 crore healthcare workers and 2 crore frontline workers when India begins the rollout of the Covid vaccine, he added.
“In 1st phase of #COVID19Vaccination free #vaccine shall be provided across the nation to most prioritised beneficiaries that incl 1 crore healthcare & 2 crore frontline workers. Details of how further 27 cr priority beneficiaries are to be vaccinated until July are being finalised (sic),” Dr Harsh Vardhan said in a tweet.
Advertisement
